Concepedia

Author

Koiti Inokuchi

Nippon Medical SchoolORCID

Also Known As

Hiroki Yamaguchi, Inokuchi K, Inokuchi, K., K Inokuchi, K. Inokuchi, Kazuyuki INOKUCHI, Keizo MATSUMOTO, Koiti INOKUCHI, Koiti Inokuchi, Mitsune Tanimoto

262

Publications

3.9K

Citations

35

H-Index

102

Concepts

All Affiliations

Nippon Medical SchoolTokyo Metropolitan Komagome HospitalOme Municipal General HospitalYokohama Minami Kyosai HospitalKyoto University
KI

About

Koiti Inokuchi is an author at Nippon Medical School specializing in medicine, hematology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

53

1.8K

2

Cell Biology

18

24

687

3

Health Sciences

14

15

580

4

Natural Sciences

4

4

190

5

Blood Transplantation

1

1

25

Koiti Inokuchi

×

85

Publications

3K

Citations

32

H-Index

YearCitations

Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse

Manoj Garg, Yasunobu Nagata, Deepika Kanojia,

Blood

2015

214

Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia

Masahiro Sakaguchi, Hiroki Yamaguchi, Yuho Najima,

Blood Advances

2018

128

Prognostic impact of <i>CEBPA</i> bZIP domain mutation in acute myeloid leukemia

Satoshi Wakita, Masahiro Sakaguchi, Iekuni Oh,

Blood Advances

2021

116

Mobile Genetic Element SCCmec-encoded psm-mec RNA Suppresses Translation of agrA and Attenuates MRSA Virulence

Chikara Kaito, Yuki Saito, Mariko Ikuo,

PLoS Pathogens

2013

115

Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1

Mariko Ishibashi, Hideto Tamura, Mika Sunakawa,

Cancer Immunology Research

2016

94

Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia

Satoshi Wakita, Hiroki Yamaguchi, Ikuko Omori,

Leukemia

2012

88

Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma

Tsuneaki Hirakawa, Hiroki Yamaguchi, Norio Yokose,

Annals of Hematology

2010

82

Functional expression of Tim-3 on blasts and clinical impact of its ligand galectin-9 in myelodysplastic syndromes

Toshio Asayama, Hideto Tamura, Mariko Ishibashi,

Oncotarget

2017

71

CD4(+) cytotoxic T-cell clones specific for bcr-abl b3a2 fusion peptide augment colony formation by chronic myelogenous leukemia cells in a b3a2-specific and HLA-DR-restricted manner.

Masaki Yasukawa, Hideki Ohminami, Shin Kaneko,

PubMed

1998

68

A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia [see comments]

Koiti Inokuchi, Takuya Inoue, Arinobu Tojo,

Blood

1991

65

Page 1